'Female Viagra' Clinical Trials Underway At The University Of Virginia

By

Female Viagra Trial

The University of Virginia is performing clinical trials on a substance called LibiGel. This product is supposed to be the female Viagra and is a testosterone-based topical solution. The point of the drug is to ease a condition called hypoactive sexual desire disorder. According to some figures, one-third of American women have this condition. We mentioned in a Dish on August 15th that a testosterone patch was recently tested on post-menopausal women with some pretty positive results. LibiGel appears to be carrying on that good work. We’re assuming that the name LibiGel is an amalgamation of ‘libido’ and ‘gelatin.’

We’re a little surprised that this research is going on at UVA. Those guys seem a little uptight. We’re pretty sure that before any research project is given a green light, the researchers have to type up a pitch about whether or not Thomas Jefferson (TJ) would approve of the project. Our guess is that something sex-related would be a given a thumbs up by TJ.

We owe it to TJ to end hypoactive sexual desire disorder in our lifetimes. We just wish that the answer wasn’t always a testosterone boost. There’s something unwholesome about trying to get a lady fired up about sex using testosterone. It would be great if they made some headway on the promising research we mentioned on April 30th, about a pill that increases sexual appetite AND stimulates weight loss (and it’s not the yayo, Frank).

Read the original article from the San Francisco Gate…

GET MORE ARTICLES LIKE THIS IN YOUR INBOX!

Sign up for our daily email and get the stories everyone is talking about.

Must-see Videos
SEE MORE VIDEOS
Stories we love
FROM AROUND THE WEB
  • Forty-eight percent of women and 43% of men say their usual sexual experience includes a deep physical and emotional connection.